
| |  | |  |
Article
|
| Functional Characterization of Polymorphisms in DNA Repair Genes Using Cytogenetic Challenge Assays William W. Au,1 Salama A. Salama,1,* and Carlos
H. Sierra-Torres2 1Department of Preventive Medicine and Community Health,
The University of Texas Medical Branch, Galveston, Texas, USA; 2Laboratorio
de Genética Humana, Departamento de Ciencas Fisiológicas,
Universidad del Cauca, Popáyan, Colombia Abstract A major barrier to understanding the role of polymorphic DNA repair genes for environmental cancer is that the functions of variant genotypes are largely unknown. Using our cytogenetic challenge assays, we conducted an investigation to address the deficiency. Using X-rays or ultraviolet (UV) light, we irradiated blood lymphocytes from 80 nonsmoking donors to challenge the cells to repair the induced DNA damage, and we analyzed expression of chromosome aberrations (CA) specific to the inducing agents. We have genotyped polymorphic DNA repair genes preferentially involved with base excision repair (BER) and nucleotide excision repair (NER) activities (XRCC1, XRCC3, APE1, XPD) corresponding to the repair of X-ray- and UV light-induced DNA damage, respectively. We expected that defects in specific DNA repair pathways due to polymorphisms would cause corresponding increases of specific CA. From our data, XRCC1 399Gln and XRCC3 241Met were associated with significant increases in chromosome deletions compared with the corresponding homozygous wild types (18.27 ± 1.1 vs 14.79 ± 1.2 and 18.22 ± 0.99 vs 14.20 ± 1.39, respectively) ; XPD 312Asn and XPD 751Gln were associated with significant increases in chromatid breaks compared with wild types (16.09 ± 1.36 vs 11.41 ± 0.98 and 16.87 ± 1.27 vs 10.54 ± 0.87, respectively) , p < 0.05. The data indicate that XRCC1 399Gln and XRCC3 241Met are significantly defective in BER, and the XPD 312Asn and XPD 751Gln are significantly defective in NER. In addition, the variant genotypes interact significantly, with limited overlap of the two different repair pathways. Key words: challenge assay, chromosome aberrations, DNA damage, DNA repair, DNA repair gene polymorphisms, genetic susceptibility. Environ Health Perspect 111:1843-1850 (2003) . doi:10.1289/txg.6632 available via http://dx.doi.org/ [Online 6 October 2003] |
|
|
 |
Address correspondence to W.W. Au, Department of Preventive
Medicine and Community Health, 700 Harborside Dr., 2.102 Ewing Hall, The University
of Texas Medical Branch, Galveston, Texas 77555-1110 USA. Telephone: (409)
772-1545. Fax: (409) 772-9108. E-mail: william.au@utmb.edu
*Current address: The University of Tennessee
at Memphis, Transplant Surgery Division, Memphis, TN 38163 USA.
The investigation received partial financial support from
a pilot project grant from the National Institute of Environmental Health
Sciences center (ES 06676) at the University of Texas Medical Branch. The
study used services from the General Clinical Research Center with funding
from the National Center for Research Resources (M01 RR-00073).
The authors declare they have no conflict of interest.
Received 5 August 2003; accepted 6 October 2003.
On a daily basis, endogenous and exogenous agents induce cellular DNA damage.
If not repaired, the damage can interfere with important cellular functions
and can cause serious health problems such as cancer. Therefore, a variety of
DNA repair processes such as the base excision repair (BER), nucleotide excision
repair (NER), and mismatch and double-strand break repairs have evolved to perform
the critical repair functions (Dybdahl et al. 1999; Friedberg 2003). The BER
pathway is involved in the repair of DNA damage caused by a variety of internal
and external factors including ionizing radiation, alkylating agents, and oxidation.
XRCC1 and Ape1 enzymes play important roles in the BER pathway. The Ape1 protein
incises the phosphodiester backbone of DNA immediately 5´ to the baseless
lesion, leaving a strand break with a normal 3´-hydroxyl group and a nonconventional
5´-abasic terminus (Wilson and Barsky 2001). XRCC1 acts as a scaffold for
other DNA repair proteins such as DNA polymerase ß and DNA ligase II (reviewed
by Caldecott 2003). The XRCC3 protein functions in the homologous DNA double-strand
break repair pathway and directly interacts with and stabilizes Rad51 (Bishop
et al. 1998). NER is the major pathway in humans for the removal of cyclopyrimidine
dimers and 6-4 photoproducts produced by ultraviolet (UV) light and a wide variety
of bulky lesions formed by chemical agents (Friedberg et al. 1995). XPD proteins
are involved in the NER pathway. They stabilize the transcription factor complex
TFIIH and have 5 3´
DNA helicase activity (Lehmann 2001).
Mutations that affect the function of DNA repair enzymes are rare in the human
population because they can cause serious health consequences. However, with
the advent of the human genome program, variations in DNA sequences of repair
genes were discovered recently (Shen et al. 1998). The surprise was that the
frequencies of the variant gene alleles, based on single nucleotide polymorphisms,
reached the polymorphism level in the population. In addition some of the polymorphisms
may not be innocuous variations because the alterations can be predicted to
cause the substitution of amino acids in the repair enzymes, presumably altering
their repair functions (Mohrenweiser and Jones 1998; Shen et al. 1998). However,
the functions of the variant genotypes have not yet been well characterized.
The discovery of DNA repair gene polymorphism has stimulated tremendous interest
in research to determine if the variant genotypes are associated with cancer.
Significant associations with lung cancer, head and neck cancer, and bladder
cancer have been reported (Butkiewicz et al. 2001; Spitz et al. 2001; Stern
et al. 2002; Sturgis et al. 2002; Tomescu et al. 2001; Zhou et al. 2003). However,
a high number of the observations were not consistent with each other (reviewed
by Benhamou and Sarasin 2002; Goode et al. 2002; Hu et al. 2002). In addition
unexpected observations were reported. For example, inheritance of XPA variant alleles was associated with reduced risk for lung cancer (Wu et al.
2003). In association with the variant genotypes for XRCC1 and ERCC3,
the risk for lung cancer decreased as the pack-years of smoking increased (Zhou
et al. 2003). There have been many proposed explanations to address the discrepancies.
The consistent recommendation is that the functional consequences of the polymorphisms
need to be characterized.
We have conducted an investigation to elucidate DNA repair function of certain
variant genotypes using our cytogenetic challenge assays (Au 1993; Au et al.
1991; El Zein et al. 1995). The challenge assays have been validated to indicate
abnormal DNA repair responses to X rays and to UV light on the basis of studies
using the host cell reactivation assay and patients with skin cancer susceptibility
(El Zein et al. 1995; Hallberg et al. 1997). Specifically, we have selected
two groups of polymorphic DNA repair genes preferentially involved with BER
and NER activities that correspond to the repair of X rays and UV light-induced
DNA damage, respectively. The relationship between variant genotypes and the
expression of X rays and UV light-induced chromosome aberrations (CA) in
normal human lymphocytes was investigated. Our assumption is that defects in
specific DNA repair pathways would lead to a corresponding increase in specific
CA. The data indicate that XRCC1 399Gln and XRCC3 241Met are associated
with defects in BER, and XPD 312Asn and XPD 751Gln with NER.
Materials and Methods
Recruitment of Donors In this study we recruited volunteers who were healthy and had a presumably
stable lifestyle. Therefore, we advertised for healthy males and females who
were in the middle age group (35-40 years of age), regardless of ethnicity.
Potential volunteers were informed about the objectives of the study, the need
to donate a blood sample, and the risk and benefit from participation in the
study. Study participants filled out a questionnaire for lifestyle information
and medical history and signed consent forms, according to the approved protocol
from the University Institutional Review Board. Exclusion criteria were smoking
of cigarettes, cigars, and pipes; previous exposure to radiation or hazardous
chemicals; on medication; and history of cancer or from cancer families. Each
qualified volunteer was asked to donate a single blood sample.
Laboratory Reagents and Cell Cultures Standard laboratory culture reagents were purchased from Gibco Laboratory
(Grand Island, NY) and from Murex Biotech (Dartford, UK). The primers for genotyping,
DNA Taq polymerase, and restriction enzymes were purchased from Sigma-Aldrich
(St. Louis, MO).
Blood specimens were collected into Vacutainer tubes (Sigma-Aldrich) containing
sodium heparin as an anticoagulant. The specimens were labeled with a predetermined
code and transported to the laboratory as soon as possible after collection.
Blood cultures were set up according to the standard procedures in our laboratory
(Au et al. 1991). The cultures were normally set up within 2 hr from the time
blood samples were drawn from the donors. The culture medium was made up of
RMPI 1640 medium that was supplemented with 10% heat-inactivated fetal bovine
serum, 2% phytohaemagglutinin, 100 U/mL penicillin, 100 µg/mL streptomycin,
and l-glutamine. Cultures were maintained in a water-jacketed CO2 incubator set up at 37.5°C.
The X-Ray Challenge Assay The challenge assay used in this study was developed in our laboratory and
discussed in detail elsewhere (Au 1993; Au et al. 1991). For this assay, blood
cultures were set up by placing 0.5 mL whole blood into culture tubes that each
contained 4.5 mL culture medium as described above (Au et al. 1991). A Mark
I cesium-137 pneumatic irradiator with a dose rate of approximately 80 cGy/min
was used for the irradiation (J.L. Shephard, Glendale, CA). The cells were irradiated
in the culture tubes 24 hr after culture initiation and the irradiation dose
was 100 cGy. Fifty hours after culture initiation, cells were harvested using
the standard Colcemid blocking procedure (Au et al. 1991).
UV-Light Challenge Assay The UV challenge assay was described in our previous publication (El Zein
et al. 1995). Under UV irradiation conditions, target cells need to be irradiated
as a monolayer and without overlap from the other cell types. Therefore, lymphocytes
were isolated from whole blood using Histopaque 1077 (Sigma-Aldrich) and used
to set up the cultures (500,000 cells/mL in 5 mL culture, using the same culture
medium described earlier). Twenty-four hours after initiation of the lymphocyte
cultures, the culture tubes were centrifuged to pack cells. The supernatant
medium was removed and saved for reuse after the irradiation. The packed cells
from each culture were resuspended in 2 mL sterile saline and put into a 100-mL
Petri dish for irradiation. With the small volume of saline, the cells were
therefore spread out into a thin layer with limited overlapping of cells. The
source of UV light was a 15-W short-wave tube that produced a peak of intensity
of 1,100 µW/cm2 of 254 nm at 15 cm distance. The irradiation
dose was 4 J/m2 for 4 sec. The irradiation was performed in a lamina
flow hood with the lids of the Petri dishes removed. After the irradiation,
cells were resuspended in their own growth medium saved earlier and allowed
to grow for an additional 26 hr before harvesting.
Cell Harvesting Before harvest, cells were blocked with Colcemid (final concentration 0.1
µg/mL) for 1.5 hr. After removal of the culture medium, cells were treated
with hypotonic solution (0.075 M KCl) and fixed with Carnoy's fixative (methanol
and glacial acetic acid at 3:1 ratio). Cytological preparations were made, coded,
and stained with 10% Giemsa solution for 15 min. The stained slides were air
dried, and a cover slip was then put onto each slide. Under the microscope,
metaphase cells were located and analyzed for the presence of CA (Au et al.
1991). Fifty metaphase cells were analyzed for every exposure condition and
the data are expressed as percentages. One individual did all analyses using
coded slides.
DNA Isolation and Genotyping Genomic DNA was extracted from isolated lymphocytes by a standard nonorganic
procedure (Miller et al. 1988). The extracted DNA was used for characterization
of the following polymorphic DNA repair genes. These polymorphic genes were
chosen because they reportedly are associated with several environmental cancers
(Butkiewicz et al. 2001; Misra et al. 2003; Smith et al. 2003; Sturgis et al.
2002; Tomescu et al. 2001; Zhou et al. 2003). Polymerase chain reaction (PCR),
followed by restriction fragment length polymorphism, was used for genotyping.
All genotype assays were performed twice, and the repeat analyses were conducted
independent of each other. Only concordant findings from these analyses were
accepted.
For determination of polymorphism XRCC1 Arg194Trp, 100 ng genomic DNA
was amplified in a total volume of 50 µL containing 0.2 µM of the
following primer pairs: forward, 5´-GCCCCGTCCCAGGTA-3´, reverse, 5´-AGC
CCC AAG ACCC TTT-3´, 1 PCR buffer (150 mM Tris-HCl, pH 0.8, 500 mM KCl), 2.5 mM MgCl2, 0.2
mM each deoxynucleoside triphosphate (dNTP), and 1 U Taq polymerase.
The PCR amplification condition consisted of initial denaturation step at 95°C
for 2 min, followed by 40 cycles of 94°C for 15 sec, 57°C for 45 sec,
72°C for 45 sec, and final extension step at 72°C for 5 min. The PCR
products (490 bp) were digested overnight with the restriction enzyme PvuII.
The restricted products of XRCC1 codon 194 Arg/Arg, Arg/Trp, and
Trp/Trp genotypes had band sizes of 490, 490/294/196, and 294/196 bp, respectively
(Hu et al. 2001).
For the XRCC1 Arg399Gln genotyping, 100 ng genomic DNA was amplified
in a total reaction volume of 50 µL containing 0.2 µM of each of the
forward primer, 5´-CAAGTACAGCCAGGTCCTAG-3´, reverse primer, 5´-CCTTCCCTCA
TCTGGAGTAC-3´, 1 PCR buffer (150 mM Tris-HCl, pH 0.8, 500 mM KCl), 1.5 mM MgCl2, 0.2
mM each dNTP, and 1 U Taq polymerase. The PCR amplification condition
consisted of initial denaturation step at 95°C for 2 min, followed by 40
cycles of 94°C for 15 sec, 55°C for 30 sec, 72°C for 45 sec,
and final extension step at 72°C for 5 min. The 248-bp PCR products were
digested with NciI (Promega, Madison, WI); the Arg allele was cut into 89 and
159 bp fragments (Gln allele not digested) (Matullo et al. 2001).
Polymorphism in exon 10 of XPD, which contains G/A, Asp312Asn,
was determined using the method described by Spitz et al. (2001). The oligonucleotide
primers 5´-CTGTTGGTGGGTGCCCGTATCTGTTGGTCT-3 (bases 22872-22901 of
XPD) and 5´-TAATATCGGGGCTCACCCTGCAGCACTTCCT (bases 23592-
23616 of XPD) were used. PCR was performed in 50-µL reaction mixtures
containing 1.5 mM MgCl2, 0.2 mM dNTP, 3% dimethyl sulfoxide, 0.2
µM primers, 100 ng template DNA, and 1.5 units Taq polymerase in
1 PCR buffer
[10 mM Tris-HCl (pH 9.0 at 25°C), 50 mM KCl, and 0.1% Triton X-100]. After
an initial denaturation at 94°C for 4 min, the DNA was amplified by 30
cycles of 1 min at 94°C, 1 min at 60°C, and 1 min at 72°C, and
then by a final extension step of 5 min at 72°C. The PCR product was digested
with StyI for 8 hr at 37°C. The digestion products were then resolved
on a 3% agarose gel containing ethidium bromide. The homozygous wild-type (Asp/Asp)
was identified by two DNA bands (507 and 244 bp), the homozygous mutant type
(Asn/Asn) produced three bands (474, 244, and 33 bp), and heterozygotes (Asp/Asn)
displayed all four bands (507, 474, 244, and 33 bp).
The XPD Lys751Gln polymorphism, a transversion A C
in exon 23 (position 35931), was determined using the primers (forward) 5´-CTGCTCAGCCTGGAG-CAGCTAGA
ATCAGAGGACGCTG-3´ and (reverse) 5´-AAGACCTTCTAGCACCACCG-3´. The
PCR condition consisted of initial denaturation step at 95°C for 2 min,
followed by 40 cycles of 94°C for 15 sec, 67°C for 30 sec, 72°C
for 45 sec, and final extension step at 72°C for 5 min. The 161-bp PCR
product was digested with PstI (Promega); the Gln allele was cut into 41- and
120-bp fragments (Lys allele not digested).
The XRCC3 Thr241Met polymorphism was determined using the primers (forward)
5´-GCCTGGTGGTCATCGACTC-3´ and (reverse) 5´-ACAGGGCTCTGGAAGGCACTGCTCAGCTCACGCACC-3´ (underlined base modifies primer sequence introducing a cut site in the presence
of the Met allele). The PCR condition consisted of initial denaturation step
at 95°C for 2 min, followed by 40 cycles of 94°C for 15 sec, 60°C
for 30 sec, 72°C for 45 sec, and final extension step at 72°C for
5 min. The 136-bp PCR product was digested with NcoI (Promega); the Met allele
was cut into 39- and 97-bp fragments (Thr allele not digested) (Matullo et al.
2001).
For XRCC3 genotyping,the XRCC3 Thr241Met polymorphism, a T C
transition in exon 7 (position 18067) was determined using the following primers:
sense, 5´-GCCTGGTGGTCATCGACTC-3´; antisense, 5´-ACAGGGCTCTGGAAGGCACTGCTCAGCTCACGCACC-3´.
The PCR conditions consisted of 100 ng genomic DNA, 1.5 mM MgCl2,
200 µM each dNTP, 0.5 U Taq, and 250 nM of each primer in 1 PCR buffer. The PCR program was as follows: a 3-min denaturation step at 94°C,
followed by 35 cycles of 95°C for 1 min, 60°C for 1 min, and 72°C
for 1 min, followed by final extension step at 72°C for 5 min. The 136-bp
PCR product was digested with NcoI restriction enzyme at 37°C for
6 hr; the Met allele was cut into 39- and 97-bp fragments (Thr allele not digested)
(Matullo et al. 2001).
For APE1 genotyping (Hu et al. 2001), the polymorphism in APE1,
exon 5, T/G, 148 Asp/Glu, was determined using the following primers: forward,
5´-CTGTTTCATTTCTATAGGCTA-3´; reverse, 5´-AGGAACTTGCGAAAGGCTTC-3´.
About 100 ng genomic DNA in a total volume of 50 µL was amplified by PCR.
The reaction mixture consisted of PCR buffer (150 mM Tris-HCl, pH 8.0,
500 mM KCl), 2.5 mM MgCl2, 0.2 mM each dNTP, 0.2 µM each primer,
and 1 U Taq polymerase. PCR conditions were 95°C for 2 min, followed
by 40 cycles of 94°C for 15 sec, 57°C for 45 sec, 72°C for 45
sec, and a final elongation step at 72°C for 5 min. The 64-bp PCR product
was digested with the BfaI restriction enzyme at 37°C for 6 hr.
The restricted products of APE1 codon 148 Asp/Asp, Asp/Glu, and Glu/Glu
genotypes are represented by band sizes of 164, 164/144/20, and 144/20 bp, respectively.
Statistical Analysis The genotype and chromosome data were collected by two individuals and entered
into a spreadsheet data file without further modification and used for statistical
analyses by a third individual. All statistical tests were performed with the
software SPSS for Windows (version 10; SPSS Inc., Chicago, IL). CA was expressed
as mean ± standard error of the mean (SE). Statistical significance was
determined using analysis of variance (ANOVA), followed by Bonferroni's correction
for multiple comparisons when the overall F-test was significant. CA
frequency was further compared using stratified analysis by genotype after adjusting
for potential confounders in a general linear model. An alpha error (p) of
less than 0.05 was used as the criterion of significance. Significant levels
(p-values) correspond to two-sided tests.
Results
Characteristics of the Study Population
Table 1
 |
A total of 80 subjects participated in the current study. The use of donated
blood specimens for the various assays was determined purely based on the availability
of blood from the donors. Whole-blood lymphocyte cultures from 61 donors were
used to investigate the effect of DNA repair polymorphisms in X-ray-induced
CA. Isolated blood lymphocyte cultures from 49 donors were used to investigate
DNA repair polymorphisms in UV-induced CA. As indicated in Table 1, there is
no significant difference in age, gender, and distribution of the different
genotypes between the entire study population and the two subpopulations. The
genotype data were based on two independent and concordant determinations of
each genotype. The distribution of the genotypes is not consistent with Hardy-Weinberg
equilibrium. This observation is probably due to our limited sample size of
a highly selective population. However, our investigation focuses on individual
responses based on genotype composition of each individual and is not based
on distribution of genotypes in the population. Therefore, the Hardy-Weinberg
equilibrium condition does not affect the significance of our investigation.
Effect of X Rays and DNA Repair Gene Polymorphisms on Chromosome Aberrations
Table
2
 |
Irradiation of the whole-blood cultures from 61 donors with X rays resulted
in the induction of different types of CA. Chromatid-type aberrations such as
breaks and exchanges and chromosome-type aberrations such as deletions and dicentrics
were observed. The frequencies of these aberrations together with aberrant cells
indicating the percentage of cells that contained any types of CA are summarized
in Table 2. Because X rays preferentially induced chromosome-type aberrations
such as deletions and dicentrics (Au et al. 2001), these aberrations were more
frequently observed than chromatid-type breaks and exchanges (Table 2). Consequently,
the aberrant cells category has high frequency as well. As shown in the table,
XPD 312 Asn and XPD 751Gln are associated with slightly reduced
aberration frequencies in most categories, with a reduction in dicentrics for
the combined heterozygous and homozygous variant XPD 312Asn and XPD 751Gln. The reduction in dicentrics corresponded to the 2-fold increase of another
type of translocation, chromatid exchanges (Table 2). Conversely, the XRCC1,
XRCC3, and APE1 variant genotypes are associated with increased
aberrations in most categories. Significant increases were observed for XRCC1 194Try in chromatid exchanges, XRCC1 399Gln in aberrant cells and deletions,
and XRCC3 241Met in deletions. Besides the mentioned significant differences,
some variations in CA frequencies across the study population were observed,
but these are normal observations in population studies. The variations are
probably influenced by the presence of other polymorphic genotypes.
Effect of Ultraviolet Light and DNA Repair Gene Polymorphisms on Chromosome
Aberrations
Table
3
 |
Irradiation of the isolated lymphocyte cultures from 49 donors with UV light
resulted in the induction of CA that can be classified as aberrant cells, chromatid
breaks, chromatid exchanges, and chromosome deletions (Table 3). Dicentrics,
a chromosome-type translocation, were rarely observed; therefore, this type
of abnormality was not meaningful for further evaluation. Chromatid-type aberrations
such as breaks and exchanges are preferentially induced by UV light (Au et al.
2001); therefore, their frequencies are high and the aberrant cells category
also has high frequencies. As shown in the table, XPD 312Asn and XPD 751Gln are consistently associated with increased CA in every evaluated category
(Table 3). Specifically, the variant genotypes are significantly associated
with increases in the aberrant cells and chromatid breaks categories. The variant
genotypes for XRCC1, XRCC3, and APE1 are associated with
increased CA in the most observed category (Table 3). However, significant association
was observed only in the aberrant cells category for the XRCC1 194Trp.
As mentioned earlier, normal variations in CA frequencies were observed.
Specificity of Genotypes on Chromosome Aberrations
Table
4
 |
By plotting the experimental data from Tables 2 and 3 into graphic formats,
we were able to visualize better the genotype-specific effects on CA. The graphic
formats also allowed us to hypothesize interactions among the different genotypes.
We found that variant gene alleles for BER (XRCC1 194Trp, XRCC1 399Gln, XRCC3 241Met, and APE1 148Glu) but not those for NER (XPD
312Asn and XPD 751Gln) are consistently associated with defective
repair of X-ray-induced DNA damage. The most revealing case involves the
expression of increased chromosome deletions preferentially induced by X rays
(Figure 1). Based on the figure, we hypothesized that the XRCC and APE variant genotypes would interact with each other but not with XPD variant
genotypes. The analyses of the interactions support our hypothesis (Table 4).
More important, gene dosage effects were documented. Additional interactions
of genotypes (in combinations of threes) were not evaluated because the sample
size for each group was too small to be meaningful.

Figure 1. Differential repair
of X-ray–induced damage by polymorphic DNA repair genes as indicated
by the chromosome deletion frequencies.
*Significant difference between the variant and WT genotypes, p < 0.05. |
As shown in Figure 2, the data indicate that the variant genotypes for NER
genes (XPD 312Asn and XPD 751Gln) are consistently associated with defective
repair of UV light-induced DNA damage, leading to significant increase
of chromatid breaks, the aberrations preferentially induced by UV light. Conversely,
the BER genes (XRCC and APE) are not significantly or consistently
involved with the repair of this type of damage. Interactive effects of variant
genotypes in the repair of UV light-induced DNA damage were further investigated.
As shown in Table 4, the only significant interactions were observed with the
XPD variant genotypes and for chromatid breaks preferentially induced
by UV light only. Significant gene-dosage effects were detected. Furthermore,
there was no significant interaction between the BER and the NER genes.

Figure 2. Differential repair
of UV light–induced damage by polymorphic DNA repair genes as indicated
by the chromatid break frequencies.
*Significant difference between the variant and WT genotypes, p < 0.05. |
Discussion
The results from ongoing investigations into the relationship between polymorphisms
in DNA repair genes and susceptibility to environmental cancer have not yet
produced consistent results (Benhamou and Sarasin 2002; Goode et al. 2002; Mohrenweiser
et al. 2003). However, the inconsistency is most likely due to the complexity
of the biological process and of molecular epidemiological investigations. A
complementary approach to investigate the role of these polymorphic genes in
human disease is to use biomarkers to conduct functional studies. Functional
investigations using biomarkers still need to be interpreted carefully on the
basis of their experimental design. For example, the use of nonsmoking healthy
volunteers would allow us a better chance to elucidate the function of the gene
alleles than the use of cigarette smokers or lung cancer patients because the
latter conditions could interfere with gene functions. Furthermore, different
biomarkers provide different quality of data for understanding the biological
mechanisms leading to disease (Bonassi and Au 2002). For example, induction
of CA and gene mutations involves the contribution of a spectrum of repair processes,
and the data can be used to indicate increased risk for cancer. On the other
hand, the presence of DNA adducts is used as a biomarker of exposure, and the
extent of DNA repair in modifying the adduct levels is not yet clear.
In our study we observed that XPD 312Asn is associated with significant
increase in UV light-induced CA (aberrant cells and cells with chromatid
breaks, shown in Table 3) but with no increase of CA from X-ray-irradiated
cultures. This indicates specific defects in NER. The chromosome data are consistent
with the involvement of the same genotype with a nonsignificant increase of
transversion p53 gene mutation in lung cancer patients (Hou et al. 2003)
but not with DNA adducts levels in lymphocytes of lung cancer patients (Pastorelli
et al. 2002). Similarly, our observation of specific DNA repair defects in XPD 751Gln is consistent with the significant increase of DNA adducts among healthy
nonsmokers (Matullo et al. 2001) and with increased transversion p53 mutation in lung cancer patients (Hou et al. 2003) but not with changes in DNA
adducts in lymphocytes of lung cancer patients (Pastorelli et al. 2002). Our
data also showed that XPD 312 Asn and XPD 751Gln are associated
with slightly reduced aberration frequencies in X-ray-challenged cells,
with more reduction in dicentrics for the combined heterozygous and homozygous
variant XPD 312Asn and XPD 751Gln (Table 2). However, this unexpected
reduction in dicentrics may be caused by the corresponding 2-fold increase of
another type of translocation, chromatid exchanges.
With respect to XRCC1 194Trp, we observed an association with increased
CA, but the increase is not consistent or indicative of specific DNA repair
defect. This is similar to the lack of association with p53 gene mutation
in oral cancer (Hsieh et al. 2003) and the lack of increased DNA adducts (Pastorelli
et al. 2002). Nevertheless, the defective DNA repair activities interacted with
XRCC1 399Gln to cause significant increase in X-ray-induced chromosome
deletions (Table 4).
XRCC1 399Gln is associated with significant and specific CA indicative
of defects in BER. This observation is consistent with the report that XRCC1 399Gln is associated with significant increase of p53 gene mutation in
oral cancer patients (Hsieh et al. 2003), significant increase of glycophorin
A mutations in normal smokers and nonsmokers (Lunn et al. 1999), and significant
increase of DNA adducts in normal nonsmokers (Matullo et al. 2001). However,
our data are not consistent with the lack of increase of p53 gene mutations
in lung cancer patients (Hou et al. 2003) and the lack of increased DNA adducts
in lung cancer patients (Pastorelli et al. 2002).
We showed that XRCC3 241Met is associated with BER defects. However,
our data are not consistent with the lack of increase of DNA adducts in healthy
donors (Matullo et al. 2001).
APE1 148Gln is associated with some repair defects and significant
interactions with XRCC3 241Met. However, we have not been able to find any biomarker
data in the literature to support or refute our observations.
On the basis of our data, we have observed a significant genotype-specific
repair defects to the inducing agents, especially XRCC1 399Gln and XRCC3
241Met for X-rays, and XPD 312Asn and XPD 751Gln for UV light.
More important, heterozygous and homozygous variant genotypes are consistently
associated with higher CA than the wild-type genes. Combinations of variant
genotypes also showed an increase in CA compared with the corresponding combined
wild-type genes. Our precise observation is supported by a variety of studies
in the literature although there are discrepancies. Most of the discrepancies
are due to incompatible comparison with different studies; for example, the
use of cigarette smokers, cancer patients, and inappropriate biomarkers in the
other investigations. We believe that we are able to show the relatively precise
response because our experimental conditions are vigorously controlled and the
conditions are favorable for the elucidation of the function of the variant
genotypes. For example; the use of X rays and UV light to elucidate DNA repair
activities is not affected by many confounding factors that can influence similar
investigations using chemicals; for example, individual differences in cellular
uptake, metabolism, and distribution of chemicals. The existence of polymorphic
chemical-metabolizing genes in the population can further complicate the interpretation
of results from studies using chemicals. In addition, the use of different types
of CA indicative of repair defects from X rays and UV light allows us to elucidate
the efficiency in DNA repair more precisely compared with other biomarkers.
Our data also indicate that the functions of the variant genotypes are complementary
to each other in the same repair pathway, with limited overlap of genes from
the other pathways. This suggests that individuals who have different variant
genotypes that act in the same repair pathway may have further elevated risk
for environmental disease due to synergistic interactions among the genotypes.
Using carefully selected DNA damage-inducing agents and appropriate biomarkers,
we have provided data to indicate that some of the variant genotypes are associated
with specific DNA repair defects. Specifically, XRCC1 399Gln and XRCC3
241Met in BER and XPD 312Asn and XPD 751Gln for NER are significantly
defective. In addition, these genotypes interact significantly with each other
without significant overlap of different repair pathways. No genotypes, either
singly or in combination, are associated with enhanced repair activities that
lead to significantly increased CA under our experimental conditions. The information
is helpful in understanding the functions of polymorphic DNA repair genes and
their role for susceptibility to environmental cancer.
|
|
 |
References Au WW. 1993. Abnormal chromosome repair and risk to develop
cancer. Environ Health Perspect 101(suppl 3):303-308.
Au WW, Badary O, Heo MY. 2001. Cytogenetic assays for monitoring
populations exposed to environmental mutagens. In: Occupational Medicine: State
of the Art Reviews (Wilkinson G, ed). Vol 16. Philadelphia:Hanley and Belfus,
345-357.
Au WW, Walker DM, Ward JB, Whorton E, Legator MS, Singh V.
1991. Factors contributing to chromosome damage in lymphocytes of cigarette
smokers. Mutat Res 260:137-144.
Benhamou S, Sarasin A. 2002. ERCC2/XPD gene polymorphisms
and cancer risk. Mutagenesis 17:463-469.
Bishop DK, Ear U, Bhattacharyya A, Calderone C, Beckett M,
Weichselbaum RR, et al. 1998. Xrcc3 is required for assembly of Rad51 complexes
in vivo. J Biol Chem 273:21482-21488.
Bonassi S, Au WW. 2002. Biomarkers in molecular epidemiology
studies for health risk prediction. Mutat Res 511:73-86.
Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris
CC. 2001. Genetic polymorphisms in DNA repair genes and risk of lung cancer.
Carcinogenesis 22:593-597.
Caldecott KW. 2003. RCC1 and DNA strand break repair. DNA Repair
(Amst) 2:955-969.
Dybdahl M, Frentz G, Vogel U, Wallin H, Nexo BA. 1999. Low
DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma
in psoriasis patients. Mutat Res 433:15-22.
El Zein R, Tyring S, Au WW. 1995. Chromosomal radiosensitivity
of lymphocytes from skin-cancer prone patients. Mutat Res 335:143-149.
Friedberg EC. 2003. DNA damage and repair. Nature 421:436-440.
Friedberg, EC, Walker GC, Siede W. 1995. DNA Repair and Mutagenesis.
Vol 17. Washington, DC:ASM Press, 698.
Goode EL, Ulrich CM, Potter JD. 2002. Polymorphisms in DNA
repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers
Prev 11:1513-1530
Hallberg LM, Bechtold WE, Grady J, Legator MS, Au WW. 1997.
Abnormal DNA repair activities in lymphocytes of workers exposed to 1,3-butadiene.
Mutat Res 383:213-221.
Hou SM, Ryk C, Kannio A, Angelini S, Falt S, Nyberg F, et al.
2003. Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors. Environ Mol Mutagen 41:37-42.
Hsieh LL, Chien HT, Chen IH, Liao CT, Wang HM, Jung SM, et
al. 2003. The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol Biomarkers
Prev 12:439-443.
Hu JJ, Mohrenweiser HW, Bell DA, Leadon SA, Miller MS. 2002.
Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol
Appl Pharmacol 185:64-73.
Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case
LD. 2001. Amino acid substitution variants of APE1 and XRCC1 genes
associated with ionizing radiation sensitivity. Carcinogenesis 22:917-922.
Lehmann AR. 2001. The xeroderma pigmentosum group D (XPD)
gene: one gene, two functions, three diseases. Genes Dev 15:15-23.
Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. 1999.
XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and
glycophorin A variant frequencies. Cancer Res 59:2557-2561.
Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano
E, et al. 2001. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA
adducts in a sample of healthy subjects. Carcinogenesis 22:1437-1445.
Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out
procedure for extracting DNA from human nucleated cells. Nuclei Acids Res 16:1215-5116.
Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR,
Barrett M, et al. 2003. Polymorphisms in the DNA repair genes XPD, XRCC1,
XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers
in Finland. Cancer Lett 191:171-178.
Mohrenweiser HW, Jones IM. 1998. Variation in DNA repair is
a factor in cancer susceptibility: a paradigm for the promises and perils of
individual and population risk estimation? Mutat Res 400:15-24.
Mohrenweiser HW, Wilson DM, Jones IM. 2003. Challenges and
complexities in estimating both the functional impact and the disease risk associated
with the extensive genetic variation in human DNA repair genes. Mutat Res 526:93-125.
Pastorelli R, Cerri A, Mezzetti M, Consonni E, Airoldi L. 2002.
Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes.
Int J Cancer 100:9-13.
Shen MR, Jones IM, Mohrenweiser H. 1998. Nonconservative amino
acid substitution variants exist at polymorphic frequency in DNA repair genes
in healthy humans. Cancer Res 58:604-608.
Smith TR, Miller MS, Lohman K, Lange EM, Case LD, Mohrenweiser
HW, et al. 2003. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility
to breast cancer. Cancer Lett 190:183-190.
Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, et al. 2001.
Modulation of nucleotide excision repair capacity by XPD polymorphisms
in lung cancer patients. Cancer Res 61:1354-1357.
Stern MC, Johnson LR, Bell DA, Taylor JA. 2002. XPD codon 751
polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol
Biomarkers Prev 11:1004-1011.
Sturgis EM, Dahlstrom KR, Spitz MR, Wei Q. 2002. DNA repair
gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell
carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 128:1084-1088.
Tomescu D, Kavanagh G, Ha T, Campbell H, Melton DW. 2001. Nucleotide
excision repair gene XPD polymorphisms and genetic predisposition to
melanoma. Carcinogenesis 22:403-408.
Wilson DM III, Barsky D. 2001. The major human abasic endonuclease:
formation, consequences and repair of abasic lesions in DNA. Mutat Res 485:283-307.
Wu X, Zhao H, Wei Q, Amos CI, Zhang K, Guo A, et al. 2003.
XPA polymorphism associated with reduced lung cancer risk and a modulating effect
on nucleotide excision repair capacity. Carcinogenesis 24:505-509.
Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al.
2003. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking,
and lung cancer risk. Cancer Epidemiol Biomarkers Prev 12:359-365.
Last Updated: November 10, 2003 |
|
 |
|
| |